BIIB Biogen
Nasdaq · SEC CIK 875045 · EDGAR
- Bought, last 12 months
- $585.12 1 purchases by 1 insiders
- Sold, last 12 months
- $905.4K 3 sales by 2 insiders
- Filings on record
- 238 since 2021-07-02, latest 2026-09-03 16:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Singhal Priya | Head of Development | — | $665.7K |
| Minor Lloyd | Dir | — | $239.7K |
| Murphy Nicole | Head of Pharm Ops, Tech | $585.12 | — |
| Godbout Sean | CAO | — | — |
| Pangalos Menelas N | Dir | — | — |
| Grogan Jane | Head of Research | — | — |
| LANGER SUSAN | Dir | — | — |
| Keeney Adam | Head of Corp. Development | — | — |
| Izzar Rachid | Head of Gbl Product Strat | — | — |
| Patolawala Monish D | Dir | — | — |
Transactions 322
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-30 | 2023-03-28 | BIIB | Singhal Priya | Head of Development | S - Sale | $270.06 | -568 | 2,842 | -17% | -$153.4K | |
| DM | 2023-03-06 | 2023-03-02 | BIIB | Singhal Priya | Head of Development | F - Tax | $268.75 | -687 | 3,410 | -17% | -$184.6K |
| D | 2023-03-06 | 2023-03-02 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +297 | 3,554 | +9% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +512 | 3,844 | +15% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Kramer Robin | CAO | F - Tax | $278.38 | -238 | 3,332 | -7% | -$66.3K |
| D | 2023-02-22 | 2023-02-17 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | M - OptEx | $0.00 | +1,920 | 46.8K | +4% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | F - Tax | $278.38 | -929 | 45.9K | -2% | -$258.6K |
| D | 2023-02-22 | 2023-02-17 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | F - Tax | $278.38 | -1,310 | 7,586 | -15% | -$364.7K |
| D | 2023-02-22 | 2023-02-17 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | M - OptEx | $0.00 | +2,561 | 10.1K | +34% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +480 | 5,579 | +9% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $278.38 | -233 | 5,099 | -4% | -$64.9K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Gregory Ginger | EVP, Human Resources | F - Tax | $278.38 | -867 | 9,280 | -9% | -$241.4K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Gregory Ginger | EVP, Human Resources | M - OptEx | $0.00 | +1,792 | 11.1K | +19% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $278.38 | -371 | 5,117 | -7% | -$103.3K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +767 | 5,884 | +15% | $0 |
| D | 2023-02-22 | 2023-02-17 | BIIB | Singhal Priya | Head of Development | F - Tax | $278.38 | -151 | 3,800 | -4% | -$42.0K |
| D | 2023-02-22 | 2023-02-17 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +460 | 3,951 | +13% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Kramer Robin | CAO | F - Tax | $286.30 | -590 | 3,570 | -14% | -$168.9K |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +1,061 | 3,932 | +37% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | M - OptEx | $0.00 | +4,023 | 48.4K | +9% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | F - Tax | $286.30 | -4,202 | 47.7K | -8% | -$1.20M |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +1,968 | 6,350 | +45% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $286.30 | -1,324 | 6,130 | -18% | -$379.1K |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +2,611 | 6,034 | +76% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $286.30 | -1,387 | 5,694 | -20% | -$397.1K |
| D | 2023-02-14 | 2023-02-10 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,211 | 3,863 | +46% | $0 |
| D | 2023-02-14 | 2023-02-10 | BIIB | Singhal Priya | Head of Development | F - Tax | $286.30 | -372 | 3,491 | -10% | -$106.5K |
| D | 2023-02-14 | 2023-02-10 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | M - OptEx | $0.00 | +3,256 | 10.0K | +48% | $0 |
| D | 2023-02-14 | 2023-02-10 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | F - Tax | $286.30 | -1,105 | 8,896 | -11% | -$316.4K |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Gregory Ginger | EVP, Human Resources | M - OptEx | $0.00 | +3,290 | 12.8K | +35% | $0 |
| DM | 2023-02-14 | 2023-02-10 | BIIB | Gregory Ginger | EVP, Human Resources | F - Tax | $286.30 | -3,306 | 12.3K | -21% | -$946.5K |
| 2023-01-27 | 2023-01-25 | BIIB | Gregory Ginger | EVP, Human Resources | A - Grant | $0.00 | +4,452 | 10.2K | +78% | $0 | |
| 2023-01-27 | 2023-01-25 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | A - Grant | $0.00 | +1,340 | 4,108 | +48% | $0 | |
| 2023-01-27 | 2023-01-25 | BIIB | Singhal Priya | Head of Development | A - Grant | $0.00 | +1,123 | 2,652 | +73% | $0 | |
| 2023-01-27 | 2023-01-25 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | A - Grant | $0.00 | +1,783 | 4,844 | +58% | $0 | |
| 2023-01-27 | 2023-01-25 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | A - Grant | $0.00 | +5,703 | 45.1K | +14% | $0 | |
| 2023-01-27 | 2023-01-25 | BIIB | Kramer Robin | CAO | A - Grant | $0.00 | +887 | 3,099 | +40% | $0 | |
| D | 2022-12-12 | 2022-12-08 | BIIB | Kramer Robin | CAO | F - Tax | $289.10 | -156 | 2,212 | -7% | -$45.1K |
| D | 2022-12-12 | 2022-12-08 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +350 | 2,368 | +17% | $0 |
| 2022-12-12 | 2022-11-14 | BIIB | Gregory Ginger | EVP, Human Resources | S - Sale | $300.11 | -5,610 | 5,711 | -50% | -$1.68M | |
| D | 2022-12-06 | 2022-12-02 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $298.90 | -39 | 2,768 | -1% | -$11.7K |
| D | 2022-12-06 | 2022-12-02 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +131 | 2,807 | +5% | $0 |
| DM | 2022-12-06 | 2022-12-02 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +1,710 | 3,250 | +111% | $0 |
| DM | 2022-12-06 | 2022-12-02 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $298.90 | -759 | 3,061 | -20% | -$226.9K |
| 2022-10-28 | 2022-10-27 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | S - Sale | $280.70 | -5,532 | 39.4K | -12% | -$1.55M | |
| DM | 2022-09-06 | 2022-09-01 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | M - OptEx | $0.00 | +4,746 | 7,109 | +201% | $0 |
| DM | 2022-09-06 | 2022-09-01 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | F - Tax | $199.79 | -2,428 | 5,737 | -30% | -$485.1K |
| DM | 2022-08-03 | 2022-08-01 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $209.26 | -319 | 2,094 | -13% | -$66.8K |
| DM | 2022-08-03 | 2022-08-01 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +1,080 | 2,170 | +99% | $0 |
| D | 2022-07-06 | 2022-07-01 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $210.63 | -148 | 2,110 | -7% | -$31.2K |
| D | 2022-07-06 | 2022-07-01 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +504 | 2,258 | +29% | $0 |
| D | 2022-07-06 | 2022-07-01 | BIIB | Kramer Robin | CAO | F - Tax | $210.63 | -74 | 2,018 | -4% | -$15.6K |
| D | 2022-07-06 | 2022-07-01 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +252 | 2,092 | +14% | $0 |
| 2022-06-17 | 2022-06-15 | BIIB | Freire Maria C | Dir | A - Grant | $0.00 | +1,370 | 2,145 | +177% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | Rowinsky Eric K | Dir | A - Grant | $0.00 | +1,370 | 19.2K | +8% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | SHERWIN STEPHEN A | Dir | A - Grant | $0.00 | +1,370 | 18.5K | +8% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | Mulligan Richard | Dir | A - Grant | $0.00 | +1,370 | 15.1K | +10% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | DORSA CAROLINE | Dir | A - Grant | $0.00 | +1,370 | 23.2K | +6% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +2,255 | 10.1K | +29% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | DENNER ALEXANDER J | Dir | A - Grant | $0.00 | +1,370 | 15.1K | +10% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | HAWKINS WILLIAM A | Dir | A - Grant | $0.00 | +1,370 | 4,190 | +49% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | Mantas Jesus B | Dir | A - Grant | $0.00 | +1,370 | 5,088 | +37% | $0 | |
| 2022-06-17 | 2022-06-15 | BIIB | JONES WILLIAM D /CA/ | Dir | A - Grant | $0.00 | +1,370 | 2,145 | +177% | $0 | |
| D | 2022-04-05 | 2022-04-01 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | — | +239 | 1,897 | +14% | — |
| D | 2022-04-05 | 2022-04-01 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $210.65 | -84 | 1,813 | -4% | -$17.7K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +594 | 1,929 | +44% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $209.79 | -175 | 1,754 | -9% | -$36.7K |
| D | 2022-02-23 | 2022-02-18 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | F - Tax | $209.79 | -659 | 44.9K | -1% | -$138.3K |
| D | 2022-02-23 | 2022-02-18 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | M - OptEx | $0.00 | +1,485 | 45.6K | +3% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +396 | 1,854 | +27% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Kramer Robin | CAO | F - Tax | $209.79 | -117 | 1,737 | -6% | -$24.5K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Guindo Chirfi | Head of Glob Prod Strat, Com | M - OptEx | $0.00 | +1,981 | 8,243 | +32% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Guindo Chirfi | Head of Glob Prod Strat, Com | F - Tax | $209.79 | -879 | 7,364 | -11% | -$184.4K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $209.79 | -110 | 1,658 | -6% | -$23.1K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +371 | 1,768 | +27% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Gregory Ginger | EVP, Human Resources | M - OptEx | $0.00 | +1,387 | 11.8K | +13% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | Gregory Ginger | EVP, Human Resources | F - Tax | $209.79 | -616 | 11.2K | -5% | -$129.2K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Vounatsos Michel | CEO, Dir | F - Tax | $209.79 | -2,746 | 67.3K | -4% | -$576.1K |
| D | 2022-02-23 | 2022-02-18 | BIIB | Vounatsos Michel | CEO, Dir | M - OptEx | $0.00 | +6,191 | 70.0K | +10% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | M - OptEx | $0.00 | +1,981 | 5,404 | +58% | $0 |
| D | 2022-02-23 | 2022-02-18 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | F - Tax | $209.79 | -977 | 4,427 | -18% | -$205.0K |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Vounatsos Michel | CEO, Dir | F - Tax | $214.59 | -8,566 | 66.1K | -11% | -$1.84M |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Vounatsos Michel | CEO, Dir | M - OptEx | $0.00 | +8,716 | 68.0K | +15% | $0 |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Guindo Chirfi | Head of Glob Prod Strat, Com | F - Tax | $214.59 | -2,342 | 6,708 | -26% | -$502.6K |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Guindo Chirfi | Head of Glob Prod Strat, Com | M - OptEx | $0.00 | +2,597 | 7,268 | +56% | $0 |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +275 | 1,594 | +21% | $0 |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Kramer Robin | CAO | F - Tax | $214.59 | -171 | 1,418 | -11% | -$36.7K |
| DM | 2022-02-15 | 2022-02-12 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | M - OptEx | $0.00 | +2,280 | 45.6K | +5% | $0 |
| DM | 2022-02-15 | 2022-02-12 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | F - Tax | $214.59 | -2,056 | 45.1K | -4% | -$441.2K |
| D | 2022-02-15 | 2022-02-12 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | M - OptEx | $0.00 | +263 | 1,489 | +21% | $0 |
| D | 2022-02-15 | 2022-02-12 | BIIB | Murphy Nicole | Head of Pharm Ops, Tech | F - Tax | $214.59 | -92 | 1,397 | -6% | -$19.7K |
| D | 2022-02-15 | 2022-02-12 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $214.59 | -122 | 1,335 | -8% | -$26.2K |
| D | 2022-02-15 | 2022-02-12 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +351 | 1,457 | +32% | $0 |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Gregory Ginger | EVP, Human Resources | M - OptEx | $0.00 | +1,672 | 11.4K | +17% | $0 |
| DM | 2022-02-15 | 2022-02-12 | BIIB | Gregory Ginger | EVP, Human Resources | F - Tax | $214.59 | -1,252 | 10.4K | -11% | -$268.7K |
| 2022-01-21 | 2022-01-19 | BIIB | Kramer Robin | CAO | A - Grant | $0.00 | +244 | 1,354 | +22% | $0 | |
| 2022-01-21 | 2022-01-19 | BIIB | Galdes Alphonse | EVP Pharmaceutical Oper, Tech | A - Grant | $0.00 | +658 | 5,064 | +15% | $0 | |
| 2022-01-21 | 2022-01-19 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | A - Grant | $0.00 | +2,825 | 43.9K | +7% | $0 | |
| 2022-01-21 | 2021-08-09 | BIIB | ALEXANDER SUSAN H | EVP Chief Legal Off, Corp Sec | G - Gift | $0.00 | -523 | 41.1K | -1% | $0 | |
| 2022-01-21 | 2022-01-19 | BIIB | Gregory Ginger | EVP, Human Resources | A - Grant | $0.00 | +1,941 | 10.0K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations